Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy.

Nieznanska H, Bandyszewska M, Surewicz K, Zajkowski T, Surewicz WK, Nieznanski K.

Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt A):2143-2153. doi: 10.1016/j.bbadis.2018.03.023. Epub 2018 Mar 28.

2.

Friedreich ataxia is not only a GAA repeats expansion disorder: implications for molecular testing and counselling.

Hoffman-Zacharska D, Mazurczak T, Zajkowski T, Tataj R, Górka-Skoczylas P, Połatyńska K, Kępczyński Ł, Stasiołek M, Bal J.

J Appl Genet. 2016 Aug;57(3):349-55. doi: 10.1007/s13353-015-0331-4. Epub 2016 Feb 23.

PMID:
26906906
3.

Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein.

Zajkowski T, Nieznanska H, Nieznanski K.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2228-39. doi: 10.1016/j.bbamcr.2015.07.002. Epub 2015 Jul 3.

4.

Prion protein impairs kinesin-driven transport.

Nieznanska H, Dudek E, Zajkowski T, Szczesna E, Kasprzak AA, Nieznanski K.

Biochem Biophys Res Commun. 2012 Sep 7;425(4):788-93. doi: 10.1016/j.bbrc.2012.07.153. Epub 2012 Aug 3.

PMID:
22885185

Supplemental Content

Loading ...
Support Center